Work

Intravenous (i.v.) busulfan (Bu) plus melphalan (Mel) is a well-tolerated preparative regimen for stem cell transplantation (SCT) in patients (pts) with advanced lymphoid malignancies

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6548

Authors: P. Kebriaei, T. Madden, N. Thapar, E. Shpall, C. Hosing, M. Qazilbash, P. Thall, I. Khouri, R. Champlin, R. Jones, B. Andersson

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2274303522

Cites:

Cited by:

Related to: 10